66 J.-H. Kim et al. candidate for molecular-targeting chemotherapy against human oral squamous cell carcinoma. Acknowledgment This paper was supported by the Korea Research Founda- tion Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund, KRF-2008-331-E00260). Also, this study was conducted in part by research funds from Gwangju University, South Korea in 2009. References [1] Webster, K.R.: The therapeutic potential of targeting the cell cycle. Expert Opin. Investig. Drugs, 7, 865–887, 1998. [2] Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D.: p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701–704, 1993. [3] Archer, S.Y., Meng, S., Shei, A., and Hodin, R.A.: p21 (WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. U.S.A., 95, 6791–6796, 1998. [4] el-Deiry, W.S., Tokino, T., Waldman, T., Oliner, J.D., Velculescu, V.E., Burrell, M., Hill, D.E., Healy, E., Rees, J.L., Hamilton, S.R., Kinezler, K.W., and Bogelstein, B.: Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res., 55, 2910–2919, 1995. [5] Polyak, K., Hamilton, S.R., Vogelstein, B., and Kinzler, K.W.: Early alteration of cell-cycle-regulated gene expres- sion in colorectal neoplasia. Am. J. Pathol., 149, 381–387, 1996. [6] Roman-Gomez, J., Castillejo, J.A., Jimenez, A., Gonzalez, M.G., Moreno, F., Rodriguez Mdel, C., Barrios, M., Maldonado, J., and Torres, A.: 5' CpG island hypermethyla- tion is associated with transcriptional silencing of the p21 (CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia. Blood, 99, 2291–2296, 2002. [7] Shin, J.Y., Kim, H.S., Park, J., Park, J.B., and Lee, J.Y.: Mechanism for inactivation of the KIP family cyclin- dependent kinase inhibitor genes in gastric cancer cells. Cancer Res., 60, 262–265, 2000. [8] Shiohara, M., Koike, K., Komiyama, A., and Koeffler, H.P.: p21WAF1 mutations and human malignancies. Leuk. Lymphoma, 26, 35–41, 1997. [9] Watanabe, H., Fukuchi, K., Takagi, Y., Tomoyasu, S., Tsuruoka, N., and Gomi, K.: Molecular analysis of the Cip1/ Waf1 (p21) gene in diverse types of human tumors. Biochim. Biophys. Acta, 1263, 275–280, 1995. [10] Zhou, B.P., Liao, Y., Xia, W., Spohn, B., Lee, M.H., and Hung, M.C.: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol., 3, 245–252, 2001. [11] Zirbes, T.K., Baldus, S.E., Moenig, S.P., Nolden, S., Kunze, D., Shafizadeh, S.T., Schneider, P.M., Thiele, J., Hoelscher, A.H., and Dienes, H.P.: Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int. J. Cancer, 89, 14–18, 2000. [12] Brugarolas, J., Moberg, K., Boyd, S.D., Taya, Y., Jacks, T., and Lees, J.A.: Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc. Natl. Acad. Sci. U.S.A., 96, 1002–1007, 1999. [13] Gartel, A.L. and Tyner, A.L.: The growth-regulatory role of p21 (WAF1/CIP1). Prog. Mol. Subcell. Biol., 20, 43–71, 1998. [14] Mooi, W.J. and Peeper, D.S.: Oncogene-induced cell senescence-halting on the road to cancer. N. Engl. J. Med., 355, 1037–1046, 2006. [15] Sharpless, N.E. and DePinho, R.A.: Telomeres, stem cells, senescence, and cancer. J. Clin. Invest., 113, 160–168, 2004. [16] Bonnesen, C., Eggleston, I.M., and Hayes, J.D.: Dietary indoles and isothiocyanates that are generated from crucifer- ous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res., 61, 6120–6130, 2001. [17] Chiao, J.W., Chung, F.L., Kancherla, R., Ahmed, T., Mittelman, A., and Conaway, C.C.: Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol., 20, 631–636, 2002. [18] Cho, S.D., Li, G., Hu, H., Jiang, C., Kang, K.S., Lee, Y.S., Kim, S.H., and Lu, J.: Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Nutr. Cancer, 52, 213–224, 2005. [19] Fimognari, C., Nusse, M., Cesari, R., Iori, R., Cantelli-Forti, G., and Hrelia, P.: Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis, 23, 581–586, 2002. [20] Gamet-Payrastre, L., Li, P., Lumeau, S., Cassar, G., Dupont, M.A., Chevolleau, S., Gasc, N., Tulliez, J., and Terce, F.: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res., 60, 1426–1433, 2000. [21] Singh, A.V., Xiao, D., Lew, K.L., Dhir, R., and Singh, S.V.: Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis, 25, 83–90, 2004. [22] Cho, N.P., Han, H.S., Leem, D.H., Choi, I.S., Jung, J.Y., Kim, H.J., Moon, K.S., Choi, K.H., Soh, Y., Kong, G., and Cho, S.D.: Sulforaphane enhances caspase-dependent apopto- sis through inhibition of cyclooxygenase-2 expression in human oral squamous carcinoma cells and nude mouse xenograft model. Oral Oncol., 2008. [23] Cohen, J.H., Kristal, A.R., and Stanford, J.L.: Fruit and vegetable intakes and prostate cancer risk. J. Natl. Cancer Inst., 92, 61–68, 2000. [24] Kohlmeier, L. and Mendez, M.: Controversies surrounding diet and breast cancer. Proc. Nutr. Soc., 56, 369–382, 1997. [25] Kolonel, L.N., Hankin, J.H., Whittemore, A.S., Wu, A.H., Gallagher, R.P., Wilkens, L.R., John, E.M., Howe, G.R., Dreon, D.M., West, D.W., and Paffenbarger, R.S. Jr.: Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev., 9, J. Clin. Biochem. Nutr.